Re: PA diagnosis delayed by the affects of

[Guest guest]

(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylateFrom WikepdeiaYESA research publication states: "We describe a series of patients with unilateral, adrenal venous sampling confirmed, primary hyperaldosteronism, whose diagnosis was delayed by the affects of dihydropyridine calcium antagonists on initial aldosterone:renin ratio assessments. Doctors should be aware of this phenomenon and consider repeat assessment after drug withdrawal even in patients who are normokalaemic at presentation." Does "dihydropyridine calcium antagonists" refer to drugs like Norvasc (amlodipine)? Max.